{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:50:56Z","timestamp":1774565456019,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2001,11,30]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1. The intra\u2010uterine environment is now believed to play a major role in the origin of many adult diseases. Illnesses in which there is significant \u2018programming\u2019 before the time of birth include hypertension, diabetes, coronary heart disease and stroke. Acting on a genetic predisposition, intra\u2010uterine triggers appear to programme the individual\u2019s metabolism and endocrine milieu and, after birth, these risk factors are then either amplified or minimized by environmental influences. The triggers operative during fetal life that have been studied most extensively are undernutrition and glucocorticoid exposure.<\/jats:p><jats:p>2. Over the past decade, a series of studies in sheep have focused on the perinatal and life\u2010long consequences of glucocorticoid exposure in mid\u2010 to late\u2010pregnancy. These studies in the sheep model have shown that maternal injections with glucocorticoids, in a manner similar to clinical treatment for women at risk of preterm birth, enhance fetal lung maturation, but were also associated with developmental and other functional alterations that are of concern. With weekly doses to the mother, there is restricted fetal growth, delayed myelination of the central nervous system, altered blood pressure soon after birth and increased insulin response to glucose challenge in early adulthood. If the glucocorticoids are given to the fetus by ultrasound\u2010guided intramuscular injection, rather than to the mother, the effects on lung maturation are similar, but growth is spared and blood pressure after birth is unaltered. Increased insulin response to glucose challenge occurs in early adulthood with glucocorticoid by either route and is independent of growth restriction.<\/jats:p><jats:p>3. The findings in experimental animals are supported by studies of children in the Western Australian Preterm Infant Follow\u2010up Study. Multivariate analyses have shown that increasing the number of glucocorticoid exposures, for the purpose of enhancing lung maturation prior to preterm birth, is associated with reduced birthweight and behavioural disorders at 3 years of age.<\/jats:p><jats:p>4. The results of these animal and clinical studies provide further support for a role of prenatal glucocorticoid exposure in triggering predisposition to adult disease. Further exploration of these models is expected to uncover the mechanisms and lead to effective strategies that may underpin clinical interventions.<\/jats:p>","DOI":"10.1046\/j.1440-1681.2001.03559.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T11:08:43Z","timestamp":1047380923000},"page":"957-961","source":"Crossref","is-referenced-by-count":54,"title":["<b>Is Prenatal Glucocorticoid Administration Another Origin Of Adult Disease?<\/b>"],"prefix":"10.1111","volume":"28","author":[{"given":"John P","family":"Newnham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6998.171"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199608000-00002"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(68)90155-6"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-3806(90)90002-G"},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","unstructured":"WhitelawA&ThoresenM.Antenatal steroids and the developing brain.Arch. Dis. Child. Fetal Neonat. Ed.2000;83: F154\u20137.","DOI":"10.1136\/fn.83.2.F154"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1590501"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(99)80011-6"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.","volume":"50","author":"Liggins G","year":"1972","journal-title":"Pediatrics"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0420323"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0450515"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1071\/RD9950351"},{"key":"e_1_2_8_13_2","unstructured":"CrowleyP.Prophylactic corticosteroids for preterm birth.Cochrane Database Syst. Rev.2000;4: 1\u201326."},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1998.tb02947.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1993.75.5.2099"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90283-6"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.1.9612036"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1520-6661(199711\/12)6:6<309::aid-mfm1>3.3.co;2-8"},{"key":"e_1_2_8_19_2","first-page":"47","article-title":"Repeated, but not single, maternal administration of corticosteroids delays myelination in the brain of fetal sheep.","volume":"4","author":"Quinlivan J","year":"1999","journal-title":"Prenat. Neonat. Med."},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","unstructured":"QuinlivanJ BeazleyLD EvansSF NewnhamJP DunlopSA.Retinal maturation is delayed by repeated but not single maternal injections of betamethasone in sheep.Eye2000;14: 93\u20138.","DOI":"10.1038\/eye.2000.20"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6661(199905\/06)8:3<81::AID-MFM3>3.0.CO;2-N"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.5.1116"},{"key":"e_1_2_8_23_2","unstructured":"QuinlivanJA DunlopSA EvansSF BeazleyLD NewnhamJP.The effects of repeated maternal and ultrasound\u2010guided fetal injections of betamethasone upon nervous system maturation in sheep.J. Soc. Gynecol. Invest.2000;7: 70 (Abstract)."},{"key":"e_1_2_8_24_2","unstructured":"MossTJ GurrinLC HardingR NewnhamJP.Repeated prenatal maternal but not fetal injections of corticosteroids reduce term birth weight increase gestational length and cause a transient reduction in blood pressure during postnatal development in sheep.J. Soc. Gynecol. Invest.2000;7: 529 (Abstract)."},{"key":"e_1_2_8_25_2","unstructured":"SlobodaDM MossTJ NewnhamJP GurrinLC ChallisJRG.Prenatal programming of postnatal glucose tolerance in sheep.J. Soc. Gynecol. Invest.2000;7: 528 (Abstract)."},{"key":"e_1_2_8_26_2","doi-asserted-by":"crossref","unstructured":"SlobodaD NewnhamJ ChallisJ.Effects of repeated maternal betamethasone administration on growth and hypothalamic\u2013 pituitary\u2013adrenal function of the ovine fetus at term.J. Endocrinol.2000;165: 79\u201391.","DOI":"10.1677\/joe.0.1650079"},{"key":"e_1_2_8_27_2","unstructured":"SlobodaDM MossTJ NewnhamJP GurrinLC ChallisJRG.Prenatal glucocorticoid treatments alter postnatal ovine HPA function.J. Soc. Gynecol. Invest.2000;7: 216 (Abstract)."},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70160-2"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","unstructured":"FrenchNP HaganR EvansS GodfreyM NewnhamJP.Repeated antenatal corticosteroids (C): Behaviour outcomes in a regional population of very preterm (VP < 33w) infants.Pediatr. Res.1998;43: 214A (Abstract no. 1252).","DOI":"10.1203\/00006450-199804001-01273"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1681.2001.03559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1681.2001.03559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:01:02Z","timestamp":1697558462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1681.2001.03559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,30]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,30]]}},"alternative-id":["10.1046\/j.1440-1681.2001.03559.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1681.2001.03559.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,30]]}}}